eelkettle5
About
Cost-effectiveness investigation of osimertinib with regard to first-line treatment of locally superior or perhaps metastatic EGFR mutation good non-small mobile lung cancer within Singapore.
Cost-effectiveness investigation of osimertinib with regard to first-line treatment of locally superior or perhaps metastatic EGFR mutation good non-small mobile lung cancer within Singapore.